Basics |
Pfizer Inc.
Pfizer Inc is a biopharmaceutical company that discovers, develops, manufactures, and markets healthcare products including medicines, and vaccines as well as many of the consumer healthcare products.
|
IPO Date: |
January 2, 1990 |
Sector: |
Healthcare |
Industry: |
Pharma |
Market Cap: |
$139.92B |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.27 | 0.89%
|
Avg Daily Range (30 D): |
$0.23 | 0.93%
|
Avg Daily Range (90 D): |
$0.29 | 1.25%
|
Institutional Daily Volume |
Avg Daily Volume: |
30.4M |
Avg Daily Volume (30 D): |
34.23M |
Avg Daily Volume (90 D): |
38.62M |
Trade Size |
Avg Trade Size (Sh.): |
311 |
Avg Trade Size (Sh.) (30 D): |
295 |
Avg Trade Size (Sh.) (90 D): |
262 |
Institutional Trades |
Total Inst.Trades: |
354,895 |
Avg Inst. Trade: |
$3.39M |
Avg Inst. Trade (30 D): |
$4.26M |
Avg Inst. Trade (90 D): |
$5.39M |
Avg Inst. Trade Volume: |
.12M |
Avg Inst. Trades (Per Day): |
64 |
Market Closing Trades |
Avg Closing Trade: |
$88.33M |
Avg Closing Trade (30 D): |
$113.85M |
Avg Closing Trade (90 D): |
$164.31M |
Avg Closing Volume: |
2.71M |
|
|
Financials |
|
TTM |
Q1 2025 |
Q4 2024 |
Basic EPS
|
$1.39
|
$.52
|
$.07
|
Diluted EPS
|
$1.38
|
$.52
|
$.07
|
Revenue
|
$ 62.46B
|
$ 13.72B
|
$ 17.76B
|
Gross Profit
|
$ 45.15B
|
$ 10.87B
|
$ 11.85B
|
Net Income / Loss
|
$ 7.91B
|
$ 2.97B
|
$ 418M
|
Operating Income / Loss
|
$ 7.39B
|
$ 2.79B
|
$ -10M
|
Cost of Revenue
|
$ 17.32B
|
$ 2.85B
|
$ 5.91B
|
Net Cash Flow
|
$ 702M
|
$ 375M
|
$ -45M
|
PE Ratio
|
18.33
|
|
|
|
|
|